Invest / Our Investors
-
Founders
-
Angels
-
Ontario Centres of Excellence, Market Readiness Program (2009)
"PlantForm has the potential to be a leader in the expanding market for biosimilar antibody drugs. It has proprietary technology capable of making complex human antibodies quickly and inexpensively. It also has a management team with the industry experience necessary for success."
John Connolly
PlantForm investor
Managing Director, York Medtech Partners
For more information about investing in PlantForm, please contact:
Don Stewart
President and CEO
don.stewart@plantformcorp.com
416.452.7242